THE EFFECT OF COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B PLUS ENTECAVIR DURING 48 WEEKS FOR CHRONIC HEPATITIS B

被引：0

作者：

Inuzuka, Tadashi ^{[1
]}

Takeda, Haruhiko ^{[1
]}

Kanesaka, Takashi ^{[1
]}

Nakajima, Jun ^{[1
]}

Matsuda, Fumihiro ^{[1
]}

Sakamoto, Azusa ^{[1
]}

Hatamaru, Keiichi ^{[1
]}

Henmi, Shinichiro ^{[1
]}

Ishikawa, Tetsuro ^{[1
]}

Saito, Sumio ^{[1
]}

Nishikawa, Hiroki ^{[1
]}

Kita, Ryuichi ^{[1
]}

Kimura, Toru ^{[1
]}

Osaki, Yukio ^{[1
]}

机构：

[1] Osaka Red Cross Hosp, Osaka, Japan

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1063A / 1063A

页数：1

共 50 条

[41] Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C
C. Xu
S. Gupta
G. Krishna
D. Cutler
S. Wirth
C. Galoppo
M. Ciocca
K. Kolz
S. Noviello
V. Sniukiene
European Journal of Clinical Pharmacology, 2013, 69 : 2045 - 2054
[42] A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin
Shakado S.
Akehi Y.
Yotsumoto K.
Fukunaga A.
Kuno S.
Tanaka T.
Sakurai K.
Iwashita H.
Ueda S.
Hirano G.
Yokoyama K.
Morihara D.
Nishizawa S.
Sakamoto M.
Anan A.
Takeyama Y.
Irie M.
Iwata K.
Sohda T.
Sakisaka S.
Clinical Journal of Gastroenterology, 2011, 4 (4) : 255 - 261
[43] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
Samanta, A
Mandalapu, A
Fisher, A
Wilson, D
de la Torre, A
Klein, KM
Koneru, B
GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
[44] 48 Weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achieving HBeAg seroconversion in chronic hepatitis B infection
Lai, Lawrence S. W.
Fung, Tang-Tat
Lai, Sik-To
Yiu, Jak
Lam, Polly
Zhang, Hai-Ying
Wong, Wai-Man
Lo, Chung-Mau
Fan, Sheung-Tat
Hui, Chee-Kin
Leung, Nancy
Lau, George K. K.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A90 - A90
[45] ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT
Liu, C. -J.
Wang, C. -C.
Yang, S. -S.
Su, C. -W.
Liao, L. -Y.
Lee, T. -H.
Chuang, W. -L.
Chen, C. -L.
Chien, R. -N.
Peng, C. -Y.
Lee, C. -M.
Lee, Y. -F.
Kao, J. -H.
Chen, P. -J.
Chen, D. -S.
JOURNAL OF HEPATOLOGY, 2013, 58 : S308 - S308
[46] Entecavir/peginterferon alfa-2a combination in the treatment of two genotypes of chronic hepatitis B patients with lamivudine resistance
Peng, Xiaoyun
Chen, Longgui
Xiao, Mingying
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (04) : 901 - 907
[47] EFFECT OF INTERFERON ALFA-2B PLUS RIBAVIRIN THERAPY ON INCIDENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS
Kurokawa, Mika
Hiromotsu, Nooki
Takeharo, Tetsuo
Ozel, Tsugiko
Yakushijin, Takayuki
Igura, Takumi
Mochizuki, Kiyoshi
Imonaka, Kazuho
Oshita, Mosohide
Hagiwara, Hideki
Mita, Eiji
Hijiok, Taizo
Inui, Yoshiaki
Katayama, Kazuhiro
Yoshihara, Horumosa
Imai, Yosuharu
Kato, Michio
Kiso, Shinichi
Kanto, Tatsuya
Kasahoara, Akinori
Hayashil, Norio
HEPATOLOGY, 2008, 48 (04) : 880A - 881A
[48] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C REPLY
Albrecht, Janice
McHutchison, John
Sulkowski, Mark
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1809 - 1809
[49] Peginterferon alfa-2b alone or in combination with lamivudine for chronic HBeAg-positive hepatitis B: a randomized controlled trial.
Janssen, HLA
van Zonneveld, M
Senturk, H
Zeuzem, S
Akarca, U
Cakaloglu, Y
Simon, K
Kit, TSM
Gerken, G
de Man, RA
Niesters, HGM
Schalm, SW
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A11 - A11
[50] A pharmacoeconomic analysis of the registration trials: Peginterferon alfa-2a plus ribvarin versus peginterferon alfa-2b plus ribavarin for treatment of genotype 1 chronic hepatitis C
Kamal, A
Lim, JK
Crockett, S
Ahmed, A
HEPATOLOGY, 2005, 42 (04) : 352A - 352A

← 1 2 3 4 5 →